SMS Pharmaceuticals Limited has informed the Exchange about Copy of Newspaper Publication
SMSPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
SMS Pharmaceuticals Limited has submitted copies of newspaper advertisements published on 1st June 2025 in The Financial Express (English) and Andhra Prabha (Telugu) regarding its audited Standalone and Consolidated Financial Results for the fourth quarter and full year ended 31st March 2025. The filing was made under SEBI Regulation 47 read with Regulation 33, which requires listed companies to publish approved financial results in newspapers. The same results are also available on the company's website at www.smspharma.com. The announcement was signed by Company Secretary Thirumalesh Tumma and filed with both BSE and NSE on 2nd June 2025.
This is a routine regulatory compliance filing confirming that the already-approved Q4 and FY25 results have been published in newspapers. No new financial information is being disclosed here, so there is unlikely to be any direct impact on the stock price. Shareholders and investors should refer to the actual financial results (already filed earlier) for any business or performance insights.